baseclick GmbH, a Tutzing, Germany-based developer of technology that allows users to label multiple dye molecules on DNA strands in a sequence-specific manner, has raised an additional €1.2m in a second round of financing.
Backers include private investors and BASF Venture Capital.
The company intends to use the funding to expand its existing activities in DNA-technologies and build up a business for diagnostic technologies.
Founded in 2008 as a spin-off from BASF SE and Ludwig-Maximilians-Universitat Munich and led by by General Manager Dr. Thomas Frischmuth, baseclick holds technology patents in labeling processes of deoxyribonucleic acid (DNA). Applications include analyses for pathogens like HIV, hepatitis, or even tumor cells, as well as detection of mutations in human, animal and plant genomes.